Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Roche offers diabetes digital health programme to UK patients

Partners with OurPath for its six-week lifestyle management programme

Roche OurPath scales

Roche has beefed up its diabetes digital health services, launching a lifestyle management programme for patients in the UK and Ireland.

The OurPath programme was developed by two Oxbridge graduates to help people live healthier lives and prevent, or reduce the symptoms of, type 2 diabetes.

OurPath has previously been offered either through the start-up’s own website or through small-scale NHS trials via GP surgeries in London. These have seen participants lose an average of 7kg, a level of weight loss that’s associated with a 50% reduction in the risk of developing diabetes.

The programme offers participants the ‘latest tech’, from activity trackers, wireless scales and mobile and desktop apps, support from a mentor and ‘the knowledge to make a lasting change’.

Roche will align the service with its blood glucose monitoring brand Accu-Chek, branding the programme as OurPath in partnership with Accu-Chek, and is aiming big for its roll-out.

The firm said it wants to put more than 750,000 people in the UK through the programme, in the process potentially saving the NHS £525m.

Mike Gibbs, president of OurPath, said: "The challenge of the 21st century is behavioural change. The diseases that are affecting us the most and crippling global healthcare economies are the ones caused by our own unhealthy lifestyles.

“Lifestyle change programmes like OurPath are critical to help improve the nation's health and get people changing their behaviours for the long term."

The deal will see Roche Diabetes Care hire and train OurPath health coaches, as well as market the programme across the country.

Beyond that the pharma firm will also look at ways to increase access to the programme through the NHS and eventually plans to roll it out on a global scale.

Brett Lewis, general manager of Roche Diabetes Care UK & Ireland, said: "I'm delighted to announce our new partnership with OurPath, whose innovative programme is already demonstrating some fantastic results. We are looking forward to a successful future together."

The digital health partnership follows Roche's acquisition of smartphone-based diabetes management platform mySugr earlier this year, integrating it into its new patient-centred health services in diabetes care arm.

Apps and services from mySugr combine diabetes coaching, therapy management, unlimited test-strips and automated data tracking. They can be integrated with a number of medical devices and Roche will keep it running as an open platform for all diabetes devices and services, irrespective of their manufacturer.

1st December 2017

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics